Pentraxin 3 levels in bronchoalveolar lavage fluid of lung transplant recipients with invasive aspergillosis.

Citation data:

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, ISSN: 1557-3117, Vol: 36, Issue: 9, Page: 973-979

Publication Year:
2017
Usage 6
Abstract Views 5
Link-outs 1
Social Media 1
Tweets 1
PMID:
28487045
DOI:
10.1016/j.healun.2017.04.007
Author(s):
Kabbani, Dima, Bhaskaran, Archana, Singer, Lianne G, Bhimji, Alyajahan, Rotstein, Coleman, Keshavjee, Shaf, Liles, W Conrad, Husain, Shahid
Publisher(s):
Elsevier BV
Tags:
Medicine
Most Recent Tweet View All Tweets
article description
Invasive aspergillosis is the most common invasive fungal infection in lung transplant recipients. The use of galactomannan testing in bronchoalveolar lavage (BAL) fluid has improved diagnosis of invasive aspergillosis; however, false-positive results can lead to overdiagnosis and unnecessary treatment. The use of proinflammatory markers such as pentraxin 3 (PTX3) may help differentiate between Aspergillus colonization and disease.

This article has 0 Wikipedia mention.